Dr. George Ekema: Visionary Leader of Ablatotech’s Healthcare Revolution

Driven by an unrelenting passion for transforming lives, Dr. George Ekema., cofounder and CEO of Ablatotech, stands as a pioneering force in the world of biotechnology. From a young age, Dr. Ekema exhibited an unquenchable thirst for knowledge, which led him to move to the United States in his teens to pursue a remarkable journey in biomedical sciences. With BS degrees in biology and chemistry, a PhD in biomedical sciences specializing in neuroscience, and a JD in intellectual property law, Dr. Ekema brings a rare blend of scientific mastery and legal expertise to his role as CEO—a combination that uniquely positions him to revolutionize the healthcare industry.

With over two decades of experience as a drug discovery and therapeutics scientist, Dr. Ekema's career has been defined by an audacious goal: to cure the incurable. He began by discovering and validating therapeutic targets before advancing into small molecule drug discovery and development. Yet, he quickly recognized that true innovation lies not in inventing external "weapons" to combat disease but in empowering the body’s natural capacity to heal itself. This transformative revelation became the foundation of Ablatotech’s mission.

My Story

Guided by the principle that the human body, when properly supported, is its own best defender, Dr. Ekema has redefined what is possible in medicine. His leadership at Ablatotech has focused on creating groundbreaking therapeutics—tools that act as "boxing gloves" for the body’s prized fighter, enabling it to deliver knockout blows to cancer, infectious diseases, chronic illnesses, and even aging itself. Ablatotech’s flagship technology, Direct Antigen Presentation via Yeast for the Treatment and Prevention of Disease (DAPYTAP), reflects Dr. Ekema’s visionary approach, delivering safer, highly effective, and incredibly affordable solutions that are accessible to even the most underserved populations.

With an inspiring blend of scientific brilliance, entrepreneurial spirit, and humanitarian dedication, Dr. Ekema is not just leading Ablatotech—he is spearheading a global revolution in healthcare. His ability to merge cutting-edge innovation with a deep commitment to equity and impact leaves no doubt that he is the right person to drive the future of medicine forward. At Ablatotech, under Dr. Ekema’s transformative leadership, the vision of delivering the future of medicine today is not just a promise—it’s a rapidly unfolding reality.